Differential effects of monophosphoryl lipid A on expression of suppressor T cell activity in lipopolysaccharide-responsive and lipopolysaccharide-defective strains of C3H mice

Lipopolysaccharide (LPS)-responsive and LPS-defective strains of C3H mice did not differ in the capacity to make an antibody response to type III pneumococcal polysaccharide or in the degree of thymus-derived suppressor cell (Ts) activity generated following exposure to type III pneumococcal polysaccharide. However, treatment with monophosphoryl lipid A (MPL) abolished the expression of Ts function in LPS-responsive but not LPS-defective mice. Since this effect was elicited by different preparations of MPL, it appears to be a general property of MPL mediated by direct action of MPL on activated Ts.

[1]  P. Baker.  Regulation of magnitude of antibody response to bacterial polysaccharide antigens by thymus-derived lymphocytes , 1990, Infection and immunity.

[2]  N. Qureshi,et al.  Inactivation of suppressor T cell activity by the nontoxic lipopolysaccharide of Rhodopseudomonas sphaeroides , 1990, Infection and immunity.

[3]  P. Baker,et al.  Enrichment of suppressor T cells by means of binding to monophosphoryl lipid A , 1990, Infection and immunity.

[4]  J. Hiernaux,et al.  Immunomodulatory activity of monophosphoryl lipid A in C3H/HeJ and C3H/HeSnJ mice , 1989, Infection and immunity.

[5]  J. Hiernaux,et al.  Ability of monophosphoryl lipid A to augment the antibody response of young mice , 1988, Infection and immunity.

[6]  J. Hiernaux,et al.  Inactivation of suppressor T-cell activity by nontoxic monophosphoryl lipid A , 1988, Infection and immunity.

[7]  N. Qureshi,et al.  Lipid A and immunotherapy. , 1984, Reviews of infectious diseases.

[8]  E. Ribi.  Beneficial modification of the endotoxin molecule. , 1984, Journal of biological response modifiers.

[9]  P. Baker,et al.  Activation of antigen-specific suppressor T cells by B cells from mice immunized with type III pneumococcal polysaccharide , 1983, The Journal of experimental medicine.

[10]  S. Vogel,et al.  Endotoxin-induced T lymphocyte proliferation. , 1983, Journal of immunology.

[11]  P. Baker,et al.  Effect of splenectomy on the expression of regulatory T cell activity. , 1978, Journal of immunology.

[12]  D. Rosenstreich,et al.  Binding of bacterial endotoxin to murine spleen lymphocytes , 1977, Infection and immunity.

[13]  D. Alling,et al.  Kinetics of the antibody response to type III pneumococcal polysaccharide. I. Evidence that suppressor cells function by inhibiting the recruitment and proliferation of antibody-producing cells. , 1976, Journal of immunology.

[14]  C. Gottlieb.  Application of transformations to normalize the distribution of plaque-forming cells. , 1974, Journal of immunology.

[15]  P. Baker,et al.  REGULATION OF THE ANTIBODY RESPONSE TO TYPE III PNEUMOCOCCAL POLYSACCHARIDE , 1973, The Journal of experimental medicine.

[16]  P. Baker,et al.  Characterization of the antibody response to type 3 pneumococcal polysaccharide at the cellular level. II. Studies on the relative rate of antibody synthesis and release by antibody-producing cells. , 1971, Immunology.

[17]  P. Baker,et al.  Characterization of the antibody response to type 3 pneumococcal polysaccharide at the cellular level. I. Dose-response studies and the effect of prior immunization on the magnitude of the antibody response. , 1971, Immunology.

[18]  P. Baker,et al.  Use of erythrocytes sensitized with purified pneumococcal polysaccharides for the assay of antibody and antibody-producing cells. , 1969, Applied microbiology.